Phase II Trial of Gefitinib in Combination with Bevacizumab as First-Line Therapy for Advanced Non-Small Cell Lung Cancer with Activating EGFR Gene Mutations: The Okayama Lung

Bibliographic Details
Title: Phase II Trial of Gefitinib in Combination with Bevacizumab as First-Line Therapy for Advanced Non-Small Cell Lung Cancer with Activating EGFR Gene Mutations: The Okayama Lung
Authors: Ichihara, E., Hotta, K., Nogami, N., Kuyama, S., Kishino, D., Fujii, M., Kozuki, T., Tabata, M., Harada, D., Chikamori, K.
Source: JOURNAL OF THORACIC ONCOLOGY. 10(3):486-491
Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN367552190&indx=1&recIds=ETOCRN367552190
Database: British Library Document Supply Centre Inside Serials & Conference Proceedings
More Details
ISSN:15560864
Published in:JOURNAL OF THORACIC ONCOLOGY
Language:English